نتایج جستجو برای: hbsab

تعداد نتایج: 240  

2017
Fu-Biao Kang Ling Wang Dian-Xing Sun

RATIONALE Tumor chemotherapy could weaken the immune system of patients, which might enhance the body sensitivities to the exogenous pathogens, among which the hepatitis B virus (HBV) infection should be concerned because of the higher chances of infection and the severe outcomes, especially in East Asia. The titer level of hepatitis B surface antibody (HBsAb) higher than 10 IU/L is considered ...

2016
Martin Feuchtenberger Arne Schäfer Axel Philipp Nigg Michael Rupert Kraus

BACKGROUND Only limited data are available on the prevalence of hepatitis B in patients with proven rheumatic diseases and thus the risk of reactivation under immunosuppressive therapy. OBJECTIVE To analyse hepatitis B serology in patients with rheumatic diseases prior to therapy. METHOD In total, 1,338 patient records were analysed for HBsAg, HBsAb and HBcAb in a cross-sectional, single-ce...

2014
Hiva Saffar Mohammed Jafar Saffar Abolghasem Ajami Ali Reza Khalilian Kian Shams-Esfandabad Araz Mohammad Mirabi

BACKGROUND The long-term duration of cell-mediated immunity induced by neonatal hepatitis B virus (HBV) vaccination is unknown. OBJECTIVES Study was designed to determine the cellular immunity memory status among young adults twenty years after infantile HB immunization. PATIENTS AND METHODS Study subjects were party selected from a recent seroepidemiologic study in young adults, who had be...

2016
Zahra Ahmadinejad Zahra Abdi Liae Saideh Salehizadeh Sedighe Mansori Neda Alijani

BACKGROUND Hepatitis B infection is a universal concern. This infection can lead to chronic liver disease and hepatocellular carcinoma. Neonates born to HBsAg-positive mothers are at high risk of chronic hepatitis B virus (HBV) infection, especially for HBeAg-positive mothers or neonates who have not received hepatitis B immunoglobulin (HBIg) and HBV vaccines. OBJECTIVES The aim of this study...

Journal: :Annals of the rheumatic diseases 2011
Joung-Liang Lan Yi-Ming Chen Tsu-Yi Hsieh Yi-Hsing Chen Chia-Wei Hsieh Der-Yuan Chen Sheng-Shun Yang

OBJECTIVE To investigate the kinetics of hepatitis B virus (HBV) viral loads and HBV reactivation in rheumatoid arthritis (RA) patients undergoing therapy with tumour necrosis factor alpha (TNFα) inhibitors. METHODS The authors investigated the virological, serological and biochemical evidence of HBV reactivation in 88 RA patients receiving anti-TNFα therapy. Levels of HBV surface (HBs) antig...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2013
Yang Tang Li-Guang Sun Chun-Shui Liu Yu-Ying Li Chun-Hui Jin Dan Li Ou Bai

OBJECTIVE HBV infection may cause damage to the immune system and induce lymphomas as a result. Some scholars have indicated that HBsAg(+) reflecting HBV infection may have a relationship with lymphoma development. This study was designed to find out the specific stage of HBV infection which may be related to lymphoma. METHODS HBV serum markers, including HBsAg, HBsAb, HBeAg, HBeAb, HBcAb wer...

ژورنال: پژوهش در پزشکی 2014
حاتمی, حسین, خداکریم, سهیلا, رمضانخوانی, علی, نوشیروان پور, پیوند, گشانی, محمود,

Abstract Background: Vaccination against hepatitis B surface antigen is the most effective way for prevention and has the capability to induce protective antibody levels (> 10 IU per liter) for most vaccinated people, but antibody titer has been shown to decrease over time. It is highly important to investigate this subject especially in the medical community and related professions as high-ris...

2014
Zary Nokhodian Majid Yaran Peyman Adibi Nazila Kassaian Marjan Meshkati Behrooz Ataei

BACKGROUND Drug injection is one of the most prominent risk factors for transmission of viral hepatitis. Prevalence of hepatitis B virus (HBV) is generally higher in prisoners compared with the general population. The object of this study was to assess the markers of HBV and related risk factors among intravenous drug users (IVDU) in prisoners. MATERIALS AND METHODS Through a cross-sectional ...

Journal: :hepatitis monthly 0
reza norouzirad biochemistry department, faculty of medicine, dezful university of medical sciences, dezful, ir iran abdol hussein shakurnia health research institue, infectious and tropical diseases research center, immunology department, faculty of medicine, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; health research institue, infectious and tropical diseases research center, immunology department, faculty of medicine, ahvaz jundishapur university of medical sciences, golestan blvd, ahvaz, ir iran. tel: +98-9163132602, fax: +98-6113332036 mohammad-ali assarehzadegan immunology department, faculty of medicine, ahvaz jundishapur university of medical sciences, ahvaz, ir iran amirarsalan serajian health education research group, jahade daneshgahi of khouzestan, ahvaz, ir iran mehdi khabazkhoob epidemiology department, faculty of health, shahid beheshti university of medical sciences, tehran, ir iran

conclusions the results showed a declining trend in anti-hbsab titers over the time after vaccination against hepatitis b virus in our region. further studies are warranted to establish the need for a booster dose in cases that are at risk of hepatitis b virus infection. results hepatitis b seroprotection rates (anti hbsab ≥ 10 iu/l) among vaccinated children and adolescents aged 1 and 18 years...

ژورنال: :یافته 0
ایرج شهرامیان eraj shahramian دانشگاه علوم پزشکی زاهدان- گروه کودکانسازمان اصلی تایید شده: دانشگاه علوم پزشکی زاهدان (zahedan university of medical sciences) عبدالوهاب مرادی abdolvahab moradi دانشگاه علوم پزشکی گلستانسازمان اصلی تایید شده: دانشگاه علوم پزشکی گلستان (golestan university of medical sciences) عباسعلی معین abbas ali moin دانشگاه علوم پزشکی زابلسازمان اصلی تایید شده: دانشگاه علوم پزشکی زابل (zabol university of medical sciences) نورمحمد نوری nor mohammad noori دانشگاه علوم پزشکی زاهدانسازمان اصلی تایید شده: دانشگاه علوم پزشکی زاهدان (zahedan university of medical sciences) غلامرضا سلیمانی gholamreza solimani دانشگاه علوم پزشکی زاهدانسازمان اصلی تایید شده: دانشگاه علوم پزشکی زاهدان (zahedan university of medical sciences)

. مقدمه: ویروس هپاتیت b یکی از شایع ترین پاتوژن های مزمن در جهان به شمار می رود. حدود 350 میلیون نفر در سراسر جهان حامل مزمن هپاتیت ب هستند. بیش از سه چهارم عفونتهای هپاتیت ب در جهان در خاور میانه و افریقا واقع میشود. آمارمتفاوتی ازآلودگی به این ویروس ازایران گزارش شده است. با توجه به اینکه درآینده نزدیک طرح واکسیناسیون متولدین 1368 در شهرستان زابل (وکل کشور) انجام خواهد شد، و از وضعیت شیوع مار...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید